SCHEMBL2016502

SCHEMBL2016502

COc1cc(C(=O)N(C)C(CCNC(=O)c2cccc(OC)n2)Cc2ccccc2)cc(OC)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.49
HCRTR2 O43614 2/20 0.49
KLKB1 P03952 1/20 0.41
CTSA P10619 1/20 0.41
SIGMAR1 Q99720 4/20 0.39
OPRM1 P35372 4/20 0.37
OPRK1 P41145 3/20 0.37
HTR1A P08908 3/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
TMEM97 Q5BJF2 2/20 0.36
HTR2A P28223 2/20 0.36
DRD3 P35462 2/20 0.36
OPRD1 P41143 1/20 0.36
HTR2C P28335 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2013880 0.96 HCRTR1 (0.46) HCRTR1HCRTR2KLKB1CTSASIGMAR1
SCHEMBL2012798 0.93 HCRTR1 (0.48) HCRTR1HCRTR2KLKB1CTSASIGMAR1
SCHEMBL2013858 0.90 HCRTR1 (0.46) HCRTR1HCRTR2KLKB1CTSASIGMAR1
SCHEMBL2014697 0.90 HCRTR1 (0.46) HCRTR1HCRTR2KLKB1CTSASIGMAR1
SCHEMBL2012216 0.86 EPHX2 (0.47) HCRTR1HCRTR2KLKB1HTR1AALDH1A1
SCHEMBL6919106 0.85 HCRTR1 (0.43) HCRTR1HCRTR2KLKB1CTSASIGMAR1
SCHEMBL2017304 0.85 HCRTR1 (0.43) HCRTR1HCRTR2KLKB1CTSASIGMAR1
SCHEMBL2011408 0.85 HCRTR1 (0.43) HCRTR1HCRTR2KLKB1CTSASIGMAR1
SCHEMBL2053123 0.83 KMT2A (0.40) HCRTR1HCRTR2KLKB1CTSAALDH1A1
SCHEMBL2013932 0.83 KMT2A (0.40) HCRTR1HCRTR2KLKB1CTSAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed